Webinar – From Complexity to Clinical Success: Innovative Solutions and Regulatory Insights for BsAbs and TsAbs

Bispecific and trispecific antibodies (BsAbs and TsAbs) are opening new possibilities in oncology and autoimmune disease treatment, but their molecular complexity presents unique challenges in CMC development and regulatory approval.

Join this webinar to explore ProBio’s CMC platform and strategies for addressing key development challenges, supported by practical case studies. Gain insights into FDA, EMA, and NMPA requirements, key CMC review considerations, and analytical and bioassay strategies for multispecific antibodies.